Get Updates

Join a local group today!

Wherever you are in the process of determining your cancer risk or risk management options, you are not alone.

Get Support > Find Your Local Group > Houston Network

| More

Houston Network

Group Sign-up

Want to meet others going through a similar journey as you?

Please sign up below to receive email updates about local meetings and events in your area.

Welcome

Judy CalabriaWelcome to the home page for the Houston Network for FORCE: Facing Our Risk of Cancer Empowered! Here you will find information on our local efforts to provide information, support, awareness, and advocacy for individuals and families affected by hereditary breast and ovarian cancer.

Our Houston Network outreach coordinator is Judy Calabria.

What's new

EMBRACA Study - PARP inhibitor clinical trial for advanced breast cancer

BioMarin is enrolling EMBRACA, a Phase 3 study of talazoparib, a PARP inhibitor, in patients with locally advanced and/or metastatic BRCA+ breast cancer. For more information on EMBRACA visit www.embracastudy.com or contact the research team at:

MD Anderson Cancer Center 
Houston, TX
Principal Investigator: Jennifer Litton, MD 
Contact: Jie Zhang    
Number: 713-792-2817    
Email: JieZhang@mdanderson.org or jlitton@mdanderson.org


Events

Check back soon for events and sign up above to receive local updates.

FORCE:Facing Our Risk of Cancer Empowered